_1573031554110.png?format=webp&height=120&width=120){kind=logo}
Propath - About the company
Propath is an unfunded company based in Hereford (United Kingdom), founded in 1998. It operates as a Provider of molecular pathology research and analysis services. Propath has not raised any funding yet. The company has 1957 active competitors, including 452 funded and 333 that have exited. Its top competitors include companies like Synthego, Antheia and Transcenta.
Company Details
PROPATH is the provider of molecular pathology research and analysis services. Its providing includes regulatory-compliant services in immunohistochemistry, biomarker method development, antibody tissue cross-reactivity assessment, digital pathology image analysis, and RNAScope among others.
- Website
- www.propath.co.uk/
- Social
- Email ID
- *****@propath.co.uk
- Phone Number
- +44 **********
Key Metrics
Founded Year
1998
Location
Hereford, United Kingdom
Stage
Unfunded
Ranked
768th among 1957 active competitors
Employee Count
20 as on Jun 30, 2026
Legal entities associated with Propath
Propath is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
PROPATH (UK) LIMITED CIN: 3224075 , Germany, Active | Jul 11, 1997 | - | 29 (As on Jun 30, 2021) |
Sign up to download Propath's company profile
Propath's funding and investors
Propath has not raised any funding rounds yet.
Propath's founders and board of directors
Founder? Claim ProfilePropath's employee count trend
Propath has 20 employees as of Jun 26. Here is Propath's employee count trend over the years:
Uncover Propath's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Propath's Competitors and alternates
Top competitors of Propath include Synthego, Antheia and Transcenta. Here is the list of Top 10 competitors of Propath, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Synthego 2012, Redwood City (United States), Acquired | Developer of CRISPR-engineered cell and gene therapies | $460M | 71/100 | |
2nd | Antheia 2013, Palo Alto (United States), Series C | Genetically engineered yeast cells to produce medicinal products | $176M | 67/100 | |
3rd | Transcenta 2019, Suzhou (China), Public | Developer of antibody-based therapeutics | $205M | 66/100 | |
4th | _1530865304957.jpg?devicePixelRatio=2&height=30&width=30){kind=logo} Judges Scientific 2002, London (United Kingdom), Public | Acquisition and development of scientific instrument businesses | - | 65/100 | |
5th | Developer of antibody drug conjugates for the treatment of broad spectrum diseases | $195M | 65/100 | ||
6th | Korro Bio 2018, Cambridge (United States), Public | Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases | $4M | 64/100 | |
7th | Fermentalg 2005, Libourne (France), Public | Innovating with algae for sustainable solutions in nutrition and environmental impact | $30.3M | 63/100 | |
8th | Microban 1994, Huntersville (United States), Acquired | Antimicrobial and odor control technologies for durable product protection and freshness | $64.6M | 63/100 | |
9th | Dewpoint Therapeutics 2018, Boston (United States), Series D | Developer of small molecule based therapeutics | $346M | 62/100 | |
10th | One Biosciences 2020, Paris (France), Series A | Developer of single-cell therapeutics solutions to treat multiple health disorders | $22.4M | 62/100 | |
768th | _1573031554110.png?devicePixelRatio=2&height=30&width=30){kind=logo} Propath 1998, Hereford (United Kingdom), Unfunded | Provider of molecular pathology research and analysis services | - | - | 29/100 |
_1523881431192.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Propath's competitors? Click here to see the top ones
Propath's Investments and acquisitions
Propath has made no investments or acquisitions yet.
Reports related to Propath
Here is the latest report on Propath's sector:
News related to Propath
Media has covered Propath for 1 event in last 1 year, It was about company updates.
•
•
NanoString expands partnerships with contract research organizationsSeeking Alpha•Sep 08, 2023•NanoString, Macrogen, Propath, Sirona Dx
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Propath
Explore our recently published companies
- Shop Wafi - Jeddah based, 2015 founded, Deadpooled company
- Bixabotanical - Mumbai based, 2015 founded, Unfunded company
- Benhurconstruction - Unfunded company
- Saalfo Tech - Mysuru based, 2016 founded, Unfunded company
- Tolia - Thane based, 1979 founded, Unfunded company
- Uvtcpl - Mumbai based, 2023 founded, Unfunded company
